The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs : Its role in the improvement of selective toxicity and the development of new drugs in clinical oncology

The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs : Its role in the improvement of selective toxicity and the development of new drugs in clinical oncology

Saved in:
Bibliographic Details
Published in:Clinical oncology (Royal College of Radiologists (Great Britain)) Vol. 8; no. 3; pp. 186 - 189
Main Author: PETTY, R. D
Format: Conference Proceeding Journal Article
Language:English
Published: Amsterdam Elsevier 1996
Subjects:
Antineoplastic agents
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Drug Design
Drug Resistance, Neoplasm - genetics
General aspects
Genes, myc - genetics
Genes, p53 - genetics
Genes, Tumor Suppressor - drug effects
Genes, Tumor Suppressor - genetics
Genetic Therapy
Humans
Medical sciences
Neoplasms - drug therapy
Neoplasms - genetics
Oncogenes - drug effects
Oncogenes - genetics
Pharmacology. Drug treatments
Antineoplastic agent
Human
C-Onc gene
Cytotoxicity
Malignant tumor
Negative therapeutic reaction
Protooncogene
Tumor suppressor gene
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0936-6555
1433-2981